Nuzenio

Clinical Endpoints

Clinical Endpoints news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 6 latest news signals 6 publisher sources 100/100 entity strength

Latest news

MoonLake’s nanobody boosts all clinical endpoints in phase 3 psoriatic arthritis trial - Fierce BiotechFierce Biotech · Mon, 10 Aug 2026 15:00:26 GMTTenax Therapeutics Announces Topline Results from Phase 3 LEVEL Clinical Trial of TNX-103 in Patients with PH-HFpEF - Investing News NetworkInvesting News Network · Mon, 10 Aug 2026 12:54:11 GMTMoonLake Announces Positive Topline Results from the Phase 3 IZAR-1 Trial of Sonelokimab in Psoriatic Arthritis Demonstrating Significant Improvements Across all Clinical Endpoints, and Reports Second Quarter 2026 Financial Results - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 11:19:23 GMTFDA to hold adcomm for Grail cancer test that failed in large, randomized trial - Endpoints NewsEndpoints News · Fri, 07 Aug 2026 16:08:00 GMTBezisterim meets motor and non-motor endpoints in phase II early Parkinson's trial. - AllSciAllSci · Thu, 06 Aug 2026 16:12:09 GMTAssessment of AAE-C1INH Disease Burden and Validation of Clinical Trial Endpoints Published in Frontiers in Immunology - The Manila TimesThe Manila Times · Thu, 06 Aug 2026 10:58:36 GMTPainful swelling and misdiagnoses disrupted daily life in Pharvaris study - Stock TitanStock Titan · Thu, 06 Aug 2026 10:50:00 GMT

Timeline

Mon, 10 Aug 2026 15:00:26 GMTMoonLake’s nanobody boosts all clinical endpoints in phase 3 psoriatic arthritis trial - Fierce Biotech
Mon, 10 Aug 2026 12:54:11 GMTTenax Therapeutics Announces Topline Results from Phase 3 LEVEL Clinical Trial of TNX-103 in Patients with PH-HFpEF - Investing News Network
Mon, 10 Aug 2026 11:19:23 GMTMoonLake Announces Positive Topline Results from the Phase 3 IZAR-1 Trial of Sonelokimab in Psoriatic Arthritis Demonstrating Significant Improvements Across all Clinical Endpoints, and Reports Second Quarter 2026 Financial Results - The Manila Times
Fri, 07 Aug 2026 16:08:00 GMTFDA to hold adcomm for Grail cancer test that failed in large, randomized trial - Endpoints News
Thu, 06 Aug 2026 16:12:09 GMTBezisterim meets motor and non-motor endpoints in phase II early Parkinson's trial. - AllSci
Thu, 06 Aug 2026 10:58:36 GMTAssessment of AAE-C1INH Disease Burden and Validation of Clinical Trial Endpoints Published in Frontiers in Immunology - The Manila Times

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Clinical Endpoints.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

6 distinct publisher/source names are currently connected to this entity page.